1. N Andrews (1999). Disorders of iron metabolism. N Engl J Med, 341, 1986-1995.
2. K.-F Lao,L Tam,Chan (2000). Third trimester iron status and pregnancy outcome in non-anaemic women; pregnancy unfavourably affected by maternal iron excess. Human Reproduction, 15(8), 1843-1848.
3. Yutaka Kohgo,Katsuya Ikuta,Takaaki Ohtake,Yoshihiro Torimoto,Junji Kato (2008). Body iron metabolism and pathophysiology of iron overload. International Journal of Hematology, 88(1), 7-15.
4. J Beard (2001). Iron biology in immune function, muscle metabolism and neural functioning. JNutr, 131, 568S-580S.
5. (2015). Jump up to: a b "What is pregnancy loss/miscarriage?. Jump up to: a b "What is pregnancy loss/miscarriage?
6. (2015). What are the symptoms of pregnancy loss/miscarriage?. What are the symptoms of pregnancy loss/miscarriage?
7. J Buss,F Torti,S Toriti (2003). The role of iron chelating in the cancer therapy. curr Med Chem, 10, 1021-1034.
8. (2001). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, 290-393.
9. Valerio,G Luis (2007). Mammalian Iron Metabolism. Toxicology Mechanisms and Methods, 17(9), 497-517.
10. P Brissot,Y Deugnier (1999). Oxford Textbook of Clinical Hepatology. Oxford Textbook of Clinical Hepatology, 133-136.
11. L Hallberg,L Rossander-Hultén (1991). Iron requirements in menstruating women. Am J Clin Nutr, 54, 1047-1058.
12. Thomas Bothwell (2000). Iron requirements in pregnancy and strategies to meet them. The American Journal of Clinical Nutrition, 72(1), 257S-264S.
13. Al-Toub Mashaal (2006). Study of serum ferritin and other hematological parameter in pregnancy. Study of serum ferritin and other hematological parameter in pregnancy, 108, 18-21.
14. E Casanueva,F Viteri (2003). Iron and oxidative stress in pregnancy. J Nutr, 133, 1700S-1708S.
15. E Lund,Fairweather-Tait Sj,S Warf (2001). Chonic exposure to high levels of dietary iron fortification increases lipid peroxidation in the mucosa of the rat large intestine. J Nutr, 131, 2928-2931.
16. A Ashok,A Anamar,Mellado,J Beena,Premkumar (2012). The effects of oxidative stress on female reproduction: a review biomedical central. The effects of oxidative stress on female reproduction: a review biomedical central, 10, 10-49.
17. Sandra Davidge,Stephane Bourque (1999). Faculty Opinions recommendation of Assessment of iron status in US pregnant women from the National Health and Nutrition Examination Survey (NHANES), 1999-2006. Faculty Opinions recommendation of Assessment of iron status in US pregnant women from the National Health and Nutrition Examination Survey (NHANES), 1999-2006.
18. Zuguo Mei,Mary Cogswell,Anne Looker,Christine Pfeiffer,Sarah Cusick,David Lacher,Laurence Grummer-Strawn (2011). Assessment of iron status in US pregnant women from the National Health and Nutrition Examination Survey (NHANES), 1999–2006. The American Journal of Clinical Nutrition, 93(6), 1312-1320.
19. C Savona-Ventura,E Grech (1991). Pregnancy complications in homozygous thalassaemia patients. J Obstet Gynaecol, 11, 175-176.
20. S Tuck,C Jensen,B Wonke,A Yardumian (1998). Pregnancy management and outcomes in women with thalassaemia major. J Pediatr Endocrinol Metab, 11, 923-928.
21. Melody Cunningham,Eric Macklin,Ellis Neufeld,Alan Cohen (2004). Complications of β-thalassemia major in North America. Blood, 104(1), 34-39.
22. Meropi Toumba,Nicos Skordis (2007). Osteoporosis Syndrome in Thalassaemia Major: An Overview. Journal of Osteoporosis, 2010(2), 1-7.
23. B Halliwell,C Gutteridge (1992). Free radicals, antioxidants and human disease: Where are we now?. J Lab Clin Med, 119, 598-260.
24. P Wardman,P Candeias (1996). Fenton centennial symposium. Radiat Res, 145, 523-531.
25. A Imlay,Linn (1988). DNA damage and oxygen radical toxicity. Science, 240, 1302-1309.
26. B Halliwell,Jmc Gutteridge (1989). Free Radicals in Biology and Medicine. Free Radicals in Biology and Medicine, 333, 56.
27. G Perry,A Nunomura,A Raina,Et (2003). A metabolic basis for Alzheimer disease. Neurochem Res, 28, 1549-1552.
28. I; Dalle-Donne,D Giustarini,R Colombo (2003). Protein carbonylation in human diseases. Trends Mol Med, 9, 169-176.
29. Isabella Dalle-Donne,Ranieri Rossi,Daniela Giustarini,Aldo Milzani,Roberto Colombo (2003). Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chimica Acta, 329(1-2), 23-38.
30. G Cighetti,L Bortone,S Sala (2001). Mechanism is action of malondialdehyde and 4-hydroxyl non enal on Xanthine oxidoreductase. Arch Biochem Biophys, 389(2), 195-200.
31. K Kose,C Yazici,O Assioglu (2001). The evaluation of lipid peroxidation and adensine Deaminase activity in patient with Behcehs disease. Clin Bio Chem, 34(2), 125-129.
32. D Del Rio,A Stewart,N Pellegrini (2005). A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis, 4, 316-328.
33. C White,H Viernes,C Krejsa,D Botta,T Kavanagh (2003). Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Analytical Biochemistry, 318(2), 175-180.
34. Yonghong Li,Pamela Maher,David Schubert (1997). A Role for 12-lipoxygenase in Nerve Cell Death Caused by Glutathione Depletion. Neuron, 19(2), 453-463.
35. U Wüllner,J Seyfried,P Groscurth,S Beinroth,S Winter,M Gleichmann,M Heneka,P-A Löschmann,J Schulz,M Weller,T Klockgether (1999). Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Research, 826(1), 53-62.
36. Makarem (1974). Report of a joint World Health Organization/Centers for Disease Control and Prevention technical consultation on the assessment of iron status at the population level. World Health Organization and Centers for Disease Control and Prevention. Report of a joint World Health Organization/Centers for Disease Control and Prevention technical consultation on the assessment of iron status at the population level. World Health Organization and Centers for Disease Control and Prevention, 1128-1135.
37. N Tietz (1995). Clinical Guide to laboratory test. Clinical Guide to laboratory test, 374-375.
38. Jouanolle Am,David Legall Jy (1997). Genetic emochromatosis. Ann. Boil.clin, 55, 189-193.
39. B Guidet,S Shah (1989). Unknown Title. Am J Physiol, 257(26), 440.
40. Rodney Levine,Donita Garland,Cynthia Oliver,Adolfo Amici,Isabel Climent,Null- Lenz,Bong-Whan Ahn,Shmuel Shaltiel,Earl Stadtman (1990). [49] Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology, 186, 464-478.
41. C Burtis,E Ashwood (1999). Text Book of Clinical Chemistry. Text Book of Clinical Chemistry, 45-47.
42. E Gitto,R Reiter,M Karbownik (2002). Causes of oxidative stress in the perinatal period. Biol. Neonate, 146(57), 81.
43. M Pernoll,James Metcalfe,Peter Kovach,Robert Wachtel,Marcia Dunham (1975). Ventilation during rest and exercise in pregnancy and postpartum. Respiration Physiology, 25(3), 295-310.
44. John West (1991). Best in Taylor's Physiological Basis of Medical Practice. Best in Taylor's Physiological Basis of Medical Practice, 12, 894.
45. U Adiga,Mns Adiga (2009). Total Antioxidant Activity in Normal Pregnancy. Online J Health Allied Scs, 8(2), 8.
46. R Hillman,P Henderson (1969). Control of marrow production by the level of iron supply. J Clin Invest, 48, 454-460.
47. Minic -Oka (2005). Evaluation of oxidative stress after intravenous iron supplementation. renal failure, 27(3), 345-351.
48. Pamela Starke-Reed,Cynthia Oliver (1989). Protein oxidation and proteolysis during aging and oxidative stress. Archives of Biochemistry and Biophysics, 275(2), 559-567.
49. M Fisher,E Stadtman (1992). Unknown Title. J. Biol. Chem, 267, 1872-1880.
50. M Thomas,R Macisaac,C Tsalamandris,George Jerums (2004). Elevated iron indices in patients with diabetes. Diabetic Medicine, 21(7), 798-802.
51. Carmen Sarah M King,Donangelo (2008). daily supplementation with iron increase lipid peroxidation in young women with iron store Experimental biology and medicine. daily supplementation with iron increase lipid peroxidation in young women with iron store Experimental biology and medicine, 233, 701-707.
52. Michael Davies,Shanlin Fu,Hongjie Wang,Roger Dean (1999). Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radical Biology and Medicine, 27(11-12), 1151-1163.
53. D Rajdl,J Racek,A Steiherova (2005). Markers of oxidative stress in diabetic mothers and their infants during delivery. Physiol Res, 54(4), 429-436.
54. Farshad Amirkhizi,Fereydoun Siassi,Sara Minaie (2008). the relation of body iron stores and oxidative stress markers related toatherosclerosis in women of reproductive ARYA Atherosclerosis. Journal, 4(4), 159-165.
55. Paik-Seong Lim,Yau-Huei Wei,York Leng,Yu (1999). et al Enhanced oxidative stress in hemodialysis patient receiving intravenousiron therapy. nephrol Dial Transplant, 14, 2680-2687.
56. M Mustafa,R Pathak,T Ahmed,R Ahmed,A Tripathi,K Guleria,B Banerjee (2010). Association of glutathione S transferase M1 and T1 gene polymorphisms and oxidative stress markers in preterm labor. Clin Biochem, 43, 1124-1128.
57. Eric Jauniaux,Adrian Watson,Joanne Hempstock,Yi-Ping Bao,Jeremy Skepper,Graham Burton (2000). Onset of Maternal Arterial Blood Flow and Placental Oxidative Stress. The American Journal of Pathology, 157(6), 2111-2122.
58. G Burton,J Hempstock,E Jauniaux (2003). The role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy. Curr Pharm Des, 11, 1327-1342.
59. E Ruder,T Hartman,J Blumberg,M Goldman (2008). Oxidative stress and antioxidants: exposure and impact on female fertility. Reprod Biomed Online, 14, 84-96.
